Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Health Science Reports
|
February 26, 2024
A budget impact analysis of a powered hybrid mattress to prevent pressure ulcers in the Austrian inpatient setting: An original research
Gerald Eichhober, Marco Voit, Franz Meyer, et al.
Journal of Medical Economics
|
July 28, 2020
Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria
Evelyn Walter, Sophie-Christin Hausberger, Evelyn Groß, et al.
Journal of Medical Economics
|
December 8, 2018
Cost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in Austria
Evelyn Walter, Thomas Berger, Barbara Bajer-Kornek, et al.
Journal of Medical Economics
|
February 4, 2026
Cost-effectiveness of vasopressin in the treatment of septic shock: insights from a European societal perspective
Evelyn Walter, Federico Ghinelli, Isabelle Goyer, et al.
The American Journal of Clinical Nutrition
|
March 2, 2024
Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective
Evelyn Walter, Christopher Dawoud, Elisabeth Hütterer, et al.
Journal of Medical Economics
|
September 28, 2023
The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria
Evelyn Walter, Matthäus Traunfellner, Martin Gleitsmann, et al.
Journal of Medical Economics
|
October 2, 2023
Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland
Evelyn Walter, Mattia Arrigo, Sigrid Allerstorfer, et al.
Bone
|
December 23, 2017
Cost-utility analysis of fracture risk assessment using microRNAs compared with standard tools and no monitoring in the Austrian female population
Evelyn Walter, Hanna Dellago, Johannes Grillari, et al.
Current Medical Research and Opinion
|
June 18, 2004
Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
Michiel E H Hemels, Siegfried Kasper, Evelyn Walter, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 16, 2021
Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach
Evelyn Walter, Felix B Langer, Philipp Beckerhinn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Health Science Reports
|
February 26, 2024
A budget impact analysis of a powered hybrid mattress to prevent pressure ulcers in the Austrian inpatient setting: An original research
Gerald Eichhober, Marco Voit, Franz Meyer, et al.
Journal of Medical Economics
|
July 28, 2020
Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria
Evelyn Walter, Sophie-Christin Hausberger, Evelyn Groß, et al.
Journal of Medical Economics
|
December 8, 2018
Cost-utility analysis of alemtuzumab in comparison with interferon beta, fingolimod, and natalizumab treatment for relapsing-remitting multiple sclerosis in Austria
Evelyn Walter, Thomas Berger, Barbara Bajer-Kornek, et al.
Journal of Medical Economics
|
February 4, 2026
Cost-effectiveness of vasopressin in the treatment of septic shock: insights from a European societal perspective
Evelyn Walter, Federico Ghinelli, Isabelle Goyer, et al.
The American Journal of Clinical Nutrition
|
March 2, 2024
Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective
Evelyn Walter, Christopher Dawoud, Elisabeth Hütterer, et al.
Journal of Medical Economics
|
September 28, 2023
The cost-of-illness and burden-of-disease of treatment-resistant depression in Austria
Evelyn Walter, Matthäus Traunfellner, Martin Gleitsmann, et al.
Journal of Medical Economics
|
October 2, 2023
Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland
Evelyn Walter, Mattia Arrigo, Sigrid Allerstorfer, et al.
Bone
|
December 23, 2017
Cost-utility analysis of fracture risk assessment using microRNAs compared with standard tools and no monitoring in the Austrian female population
Evelyn Walter, Hanna Dellago, Johannes Grillari, et al.
Current Medical Research and Opinion
|
June 18, 2004
Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
Michiel E H Hemels, Siegfried Kasper, Evelyn Walter, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
November 16, 2021
Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach
Evelyn Walter, Felix B Langer, Philipp Beckerhinn, et al.
Page
of 3